Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 26Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 15Head and Neck Neoplasms 13Rectal Neoplasms 11Colonic Neoplasms 11Prostatic Neoplasms 8Pancreatic Neoplasms 7Mouth Neoplasms 6Glioblastoma 6Neuroblastoma 5Neoplasm Metastasis 5Esophageal Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Recurrence 4Precancerous Conditions 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma, Hepatocellular 4Adenomatous Polyposis Coli 4Sarcoma 3

Interventions

Cisplatin 6Cetuximab 4Drug Therapy 3Resistance Training 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Nutritional Status 2Hydroxyurea 2Fluorouracil 2Erlotinib Hydrochloride 2Bevacizumab 2zimberelimab 1temsirolimus 1Valproic Acid 1Sirolimus 1Radiation 1Psychology, Positive 1Methods 1Metabolic Flux Analysis 1Immunoglobulin G 1Etoposide 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cryosurgery 1Chemoradiotherapy 1Celecoxib 1Carboplatin 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pharyngeal Neoplasms × Celecoxib × Clear all
NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
15 enrolled 16 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡